DiaMedica Therapeutics Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
DiaMedica Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2018 to Q4 2023.
  • DiaMedica Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2023 was $709K, a 210% increase year-over-year.
  • DiaMedica Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was $1.93M, a 446% increase year-over-year.
  • DiaMedica Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $1.93M, a 446% increase from 2022.
  • DiaMedica Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $353K, a 330% increase from 2021.
  • DiaMedica Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $82K, a 81.1% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $1.93M $709K +$480K +210% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $1.45M $693K +$617K +812% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $832K $271K +$258K +1985% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $574K $256K +$221K +631% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $353K $229K +$222K +3171% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $131K $76K +$103K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $28K $13K -$85K -86.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $113K $35K +$31K +775% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $82K $7K -$68K -90.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 $150K -$27K -$155K -121% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $305K $98K -$145K -59.7% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $450K $4K +$16K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $434K $75K -$1.13M -93.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $1.57M $128K -$97K -43.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $1.66M $243K +$523K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $1.14M -$12K +$166K +93.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $975K $1.21M +$1.05M +646% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-10
Q3 2019 -$71K $225K +$68K +43.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$139K -$280K -$411K -314% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $272K -$178K -$835K -127% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $1.11M $162K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-23
Q3 2018 $157K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $131K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $657K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.